Ask in Claude
Ask in ChatGPT
11 episodes
The Readout Loud
by STAT · English
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Latest episodes
All episodes
421: The future of heart drug research in the wake of study setbacks
The episode reviews cardiovascular and biotech setbacks and what they mean for future heart drug research. It covers Vertex’s IgA nephropathy drug POV (FDA decision due Nov.
13 Nov 2026 · 20m · 5 chapters420: Democrats’ midterm victory, and a questionable fertility procedure
The episode has two parts: (1) women over 40 seeking fertility help abroad via mitochondrial replacement techniques (MRT)/“three-parent IVF,” and (2) implications of Democrats’ midterm victory for…
6 Nov 2026 · 29m · 14 chapters419: Assessing Merck and Moderna's mRNA cancer vaccine
Live reporting from ESMO in Spain on cancer-research highlights, focusing on Merck/Moderna’s personalized mRNA melanoma vaccine (IntisMiran) plus major lung-cancer and KRAS-targeted results.
30 Oct 2026 · 20m · 13 chapters418: Remembering STAT’s Helen Branswell
A special episode of STAT’s The Read Out Loud remembering Helen Branswell, an infectious-disease journalist who died Oct. 13 at 69 after a recurrence of breast cancer.
23 Oct 2026 · 35m · 12 chapters417: Hospitals' next lucrative bet — longevity clinics
Episode 417 discusses how major hospitals are launching “longevity clinics” as a lucrative, cash-pay business aimed at extending healthspan/lifespan.
16 Oct 2026 · 20m · 11 chapters416: NIH funding uncertainty thwarts U.S. researchers
The episode focuses on NIH funding uncertainty and how policy changes are disrupting U.S. biomedical research, alongside biotech market gloom and related science news.
8 Oct 2026 · 34m · 18 chapters415: Mistrust in science and a juicy gene-editing lawsuit
The episode argues that U.S. mistrust in science has grown since COVID and is now shaping policy, driven by fear-based emotions, distrust of authority, and messaging that treats people as “customers”…
1 Oct 2026 · 31m · 12 chaptersThe FDA's Overton era, and dispatches from Shanghai
The episode examines President Trump’s nominee for FDA commissioner, Heidi Overton, amid recent FDA turmoil and politicization claims, then shifts to a Shanghai dispatch on the rise of Chinese…
24 Sep 2026 · 30m · 13 chaptersDefinium's new psychedelics data, and a reprieve for international scientists
The episode covers two biotech themes: (1) psychedelics momentum and (2) a legal reprieve for international scientists in the U.S., plus shorter biotech updates.
17 Sep 2026 · 28m · 12 chaptersWhy two promising heart drugs flopped and what's next
The episode reviews recent biotech news and focuses on why two heart-disease drug approaches failed: Novartis’s lipoprotein(a) (Lp(a)) cardiovascular outcomes trial and Novo Nordisk’s IL-6…
10 Sep 2026 · 31m · 16 chapters411: Capricor's data clash and a fugitive in the C-suite
The episode of STAT’s The Read Out Loud covers biotech and policy news plus a true-crime biotech angle.
30 Jul 2026 · 37m · 13 chaptersWe use cookies.They keep VO running smoothly and help us improve it. Privacy policy